KoreaTimes - Bio

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Business

Bio

Sun, January 29, 2023 | 07:34

SK Bioscience recruits experts for global expansion

SK Bioscience recruits experts for global expansion

SK Bioscience, developer of SKYCovione, Korea's first COVID-19 vaccine, has recruited renowned executives who have worked for global biopharmaceutical companies as part of its efforts to advance into the global market and diversify, according to the company, Friday. The company said it appointed Richard Kensinger as vice president of R&D project management at its U.S. branch,...

Baek Byung-yeul | 2023-01-20 14:40

Korea to invest $222.9 million in bio RD projects in 2023

Korea to invest $222.9 million in bio RD projects in 2023

Korea will extend 274.6 billion won ($222.9 million) for research and development in the bio industry this year, the industry ministry said Friday.

2023-01-20 10:35

S. Korea seeks to attract $500 mil. in investment from two European bio firms

S. Korea seeks to attract $500 mil. in investment from two European bio firms

South Korea's Industry Minister Lee Chang-yang met with top executives of Germany's Merck Life Science and Switzerland-based Novartis on Thursday in Davos, Switzerland, to discuss their potential investment in South Korea worth $500 million combined, his office said.

2023-01-19 20:22

SK Biopharmaceuticals to unveil wearable devices at CES 2023

SK Biopharmaceuticals to unveil wearable devices at CES 2023

SK Biopharmaceuticals will unveil its wearable healthcare devices at the upcoming Consumer Electronics Show (CES) next month as part of its plan to advance into the digital healthcare business, its head of R&D said Wednesday. “The bio industry is changing by converging with ICT. We believe there will be a patient-centric period in the bio industry and we will try to lead the ...

Baek Byung-yeul | 2022-12-14 16:35

CHA Vaccine Institute to develop mixed vaccine for COVID-19, influenza

CHA Vaccine Institute to develop mixed vaccine for COVID-19, influenza

CHA Vaccine Institute is developing a mixed vaccine that can offer protection against both COVID-19 and influenza as part of its efforts to prevent multiple diseases with a single dose, the biotech company said Tuesday. The company said it has been developing the mixed vaccine using its own immunity-enhancing platform, L-pampo, to increase immunity against both COVID-19 and i...

2022-12-13 17:08

Gov't seeks to accelerate innovation in bio industry with AI, big data

Gov't seeks to accelerate innovation in bio industry with AI, big data

The government has unveiled a plan to speed up innovation in the biopharmaceutical industry by introducing advanced digital technologies such as artificial intelligence and big data, according to the Ministry of Science and ICT, Wednesday.

Kim Jae-heun | 2022-12-07 16:25

Seegene struggles to stay afloat as pandemic ebbs

Seegene struggles to stay afloat as pandemic ebbs

Seegene, which had enjoyed the soaring popularity of its COVID-19 PCR test kits, has been struggling to stay afloat as the pandemic has been ebbing, according to industry analysts, Monday. They said the time has passed for Seegene to enjoy high growth as the number of COVID-19 infections has gradually declined globally and much of the world is shifting to endemic mode.

Baek Byung-yeul | 2022-11-14 16:51

'Agility, digitalization are key edges of Samsung Biologics'

'Agility, digitalization are key edges of Samsung Biologics'

FRANKFURT - Samsung Biologics has been increasing its presence in the global contract development and manufacturing organization (CDMO) business, generating larger revenues than market expectations this year. Such growth was possible thanks to its agile response to improve production capacity and achieving a digital transformation, according to its executives, Tuesday.

Baek Byung-yeul | 2022-11-07 14:11

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs

Yuyu Pharma aims to grow bigger with dry eye, hair loss drugs

FRANKFURT - Robert Yu, president and CEO of Yuyu Pharma, said Wednesday that his mission is to make the company comparable to prominent biopharmaceutical companies in the world. To that end, he said the Korean company is actively diversifying its portfolio by developing new drugs such as a dry eye treatment as well as hair loss medication.

Baek Byung-yeul | 2022-11-06 11:51

Contract manufacturing emerges as new opportunity for Korean bio firms

Contract manufacturing emerges as new opportunity for Korean bio firms

FRANKFURT - The CPHI exhibition has become a place for finding new growth engines for Yungjin Pharm, Daewon Pharmaceutical, Kyongbo Pharm and other small Korean bio companies as they actively try to attract new clients for their contract manufacturing organization (CMO) business, according to the companies, Wednesday.

Baek Byung-yeul | 2022-11-03 16:09

1 2 3 4 5 6 7

Top 10 Stories

1	People attempt to cut surging heating costs with creative solutions

2	Cabinet ministries turn deaf ear to watchdog's advice on sexual minorities

3	More Korean manufacturers enjoy Georgia's hospitality

4	Seoul to work with Hanoi to pursue peace on Korean peninsula

5	Superintendent of Seoul Education Office gets suspended jail term

6	SK E&S retains gov't support for Barossa gas project in Australia

7	Indonesia celebrates 50th anniversary of diplomatic ties with Korea via virtual event

8	LGES to capitalize on US IRA, Tesla partnership to continue record earnings

9	KT&G aims to become global top-tier company

10	Middle East 'sales diplomacy' picks up speed

DARKROOM